U.S. Markets closed

Former MedImmune president Greenleaf tapped to lead Canadian biotech

Morgan Eichensehr
Former MedImmune president Greenleaf tapped to lead Canadian biotech

Peter Greenleaf was most recently CEO of Baltimore-based Cerecor Inc., a rare disease therapy company that topped the BBJ's list of fastest-growing public companies last year.